Clinical validation of combinatorial pharmacogenomic testing and single-gene guidelines in predicting psychotropic medication blood levels and clinical outcomes in patients with depression
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical validation of combinatorial pharmacogenomic testing and single-gene guidelines in predicting psychotropic medication blood levels and clinical outcomes in patients with depression
Authors
Keywords
GeneSight, Combinatorial pharmacogenomics, Pharmacokinetics, CPIC guidelines, Clinical validity, Medication blood levels, Depression
Journal
PSYCHIATRY RESEARCH
Volume 296, Issue -, Pages 113649
Publisher
Elsevier BV
Online
2020-12-17
DOI
10.1016/j.psychres.2020.113649
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combinatorial Pharmacogenomic Algorithm is Predictive of Citalopram and Escitalopram Metabolism in Patients with Major Depressive Disorder
- (2020) Richard C. Shelton et al. PSYCHIATRY RESEARCH
- Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study
- (2019) John F. Greden et al. JOURNAL OF PSYCHIATRIC RESEARCH
- PharmGKB summary
- (2019) Rachel Huddart et al. Pharmacogenetics and Genomics
- Impact of CYP2C19 Genotype on Escitalopram Exposure and Therapeutic Failure: A Retrospective Study Based on 2,087 Patients
- (2018) Marin M. Jukić et al. AMERICAN JOURNAL OF PSYCHIATRY
- Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update
- (2018) Elizabeth J. Phillips et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- How is genetic testing evaluated? A systematic review of the literature
- (2018) Erica Pitini et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Analytical validation of a psychiatric pharmacogenomic test
- (2018) Michael R Jablonski et al. Personalized Medicine
- Genotype, phenotype, and medication recommendation agreement among commercial pharmacogenetic-based decision support tools
- (2018) Chad A. Bousman et al. PHARMACOGENOMICS JOURNAL
- The effect of pharmacogenomic testing on response and remission rates in the acute treatment of major depressive disorder: A meta-analysis
- (2018) Joshua D. Rosenblat et al. JOURNAL OF AFFECTIVE DISORDERS
- Escitalopram plasma levels and antidepressant response
- (2017) Vincenzo Florio et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Biomarkers of adverse drug reactions
- (2017) Daniel F Carr et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Smoking and antidepressants pharmacokinetics: a systematic review
- (2017) Pedro Oliveira et al. Annals of General Psychiatry
- The challenges of implementing pharmacogenomic testing in the clinic
- (2017) Ann M Moyer et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Implementation of a multidisciplinary pharmacogenomics clinic in a community health system
- (2016) H. M. Dunnenberger et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Implementation of inpatient models of pharmacogenetics programs
- (2016) L. H. Cavallari et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder
- (2016) Sidney H. Kennedy et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline forCYP2D6andCYP2C19Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors
- (2015) JK Hicks et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Antidepressant use in the elderly: the role of pharmacodynamics and pharmacokinetics in drug safety
- (2015) Janet Sultana et al. Expert Opinion on Drug Metabolism & Toxicology
- Clinical validity: Combinatorial pharmacogenomics predicts antidepressant responses and healthcare utilizations better than single gene phenotypes
- (2015) C A Altar et al. PHARMACOGENOMICS JOURNAL
- Utility of integrated pharmacogenomic testing to support the treatment of major depressive disorder in a psychiatric outpatient setting
- (2013) Daniel K. Hall-Flavin et al. Pharmacogenetics and Genomics
- Using a pharmacogenomic algorithm to guide the treatment of depression
- (2012) D K Hall-Flavin et al. Translational Psychiatry
- Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy
- (2011) Stefano Porcelli et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- PharmGKB summary
- (2011) Katrin Sangkuhl et al. Pharmacogenetics and Genomics
- A standardized framework for the validation and verification of clinical molecular genetic tests
- (2010) Christopher J Mattocks et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- CYP2C19 variation and citalopram response
- (2010) David A. Mrazek et al. Pharmacogenetics and Genomics
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now